Solara Active Pharma Sciences Ltd

Premium

Healthcare

22 October, 2020

Tracing Ascent Capital's returns from partial exit in drug ingredients maker

Homegrown private equity firm Ascent Capital appears to have scored neat returns from a partial exit in one of India’s ......

Premium

Healthcare

15 January, 2020

TPG Growth infuses fresh dose of capital into Indian drugmaker

TPG Growth, the mid-market and growth equity platform of private equity firm TPG, has increased its exposure to a bulk-drugs ......

Premium

Healthcare

06 November, 2019

Why Indian bulk-drug makers are attracting greater investor interest

Private equity investors as well as pharmaceutical companies are showing higher interest in the bulk-drugs segment in India, industry executives ......

Premium

Healthcare

01 February, 2019

TPG Growth bets on Indian mid-sized bulk drugs firm

TPG Growth, the mid-market and growth equity platform of private equity firm TPG, has bet on a bulk-drugs company in ......